Matthew McFarland

Matthew McFarland is a Managing Director and Partner at BroadOak Capital Partners, operating out of the San Francisco Bay Area in Brisbane, California. With over 15 years of professional experience in investment banking and corporate finance, he currently leads the firm's mergers and acquisitions advisory practice dedicated to the pharmaceutical services sector. Before co-founding BroadOak, McFarland executed middle-market transactions at Morgan Stanley, managed business development initiatives for the life sciences startup AirOcare, and served as a financial analyst at Computer Sciences Corporation. His academic credentials include a Master of Business Administration in Finance from the University of Maryland and a Bachelor of Arts in Economics from Dickinson College. Recently leading an August 2025 funding round for KROMATID, McFarland maintains a primary focus on growth capital investing and strategic advisory within the life sciences ecosystem.